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Abstract
Background: Globally, 220 million women experience an unmet need for family planning. A newly designed
female condom, the Woman’s Condom (WC), has been developed featuring an improved design. It is the first
dual-protection, female-initiated contraceptive that is a premium, higher price point product. However, market
availability alone will not increase uptake. In February 2016 the WC will be distributed with a strong media
campaign and interpersonal communication (IPC) outreach intervention. The impact of these on knowledge,
acceptability, and use of the WC will be measured.
Methods/design: A baseline survey of 2314 randomly selected 18- to 24-year-old sexually active men and women
has been conducted. The WC and mass media will be introduced throughout 40 urban wards in and surrounding
Lusaka, Zambia. The baseline survey will serve as a quasi-control arm to determine the impact of introducing the
WC with mass media. Half of the wards will be randomly allocated to additionally receive the IPC intervention. A
single-blind randomized controlled trial will determine the impact of the IPC intervention on knowledge, uptake,
and use of the WC. After one year, another 2314 individuals will be randomly selected to participate in the endline
survey.
We hypothesize that (1) the distribution and media campaign of the WC will increase overall condom use in
selected urban wards, and specifically use of the WC; (2) the IPC intervention will significantly impact knowledge,
acceptability, and use of the WC.
The primary outcome measures are use of the WC, use of any condom, and willingness to use the WC. Secondary
outcomes include measures of knowledge, acceptability, and choice of contraception.
Odds ratios will be estimated to measure the effect of the intervention on the outcomes with 95% confidence
intervals. All analyses will be based on the intention-to-treat principle.
Discussion: Increasing uptake of dual prevention measures (such as the WC) may reduce incidence of sexually
transmitted infections/HIV and unplanned pregnancies. It is important to ensure young, urban adults have access to
new contraceptive methods; and, understanding how mass media and IPC impact contraceptive knowledge,
acceptability, and use is critical to reduce unmet need.
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Background
Globally, 220 million women experience an unmet need
for family planning (FP) [1], and more than 100 million
women cite method-related reasons for non-use of mod-
ern contraceptives [2]. There is a need to diversify the
contraceptive choices for women who have different
needs, particularly in developing countries, where
women are at high risk for sexually transmitted infec-
tions (STIs) such as HIV and may lack control over sex-
ual and reproductive decisions due to gender inequity
[3]. The Expanding Effective Contraceptive Options
(EECO) project was designed to support the research,
development, and introduction of new contraceptive
methods, with the goals of addressing method-related
reasons for non-use, expanding contraceptive choice,
and increasing access to woman-initiated methods in
order to meet the reproductive health needs of women
and girls worldwide. However, just having a product
available does not mean it will be used; strategies to in-
crease uptake are still necessary and often lack evidence.
Through the EECO project, a third generation, newly
designed premium female condom (FC) called the
Woman’s Condom (WC), developed by the Program for
Appropriate Technology in Health (PATH), has
been marketed in Zambia under the brand name Max-
imum Diva Woman’s Condom (WC) by the Society for
Family Health (SFH), the Zambian subsidiary of Popula-
tion Services International (PSI). Previous iterations of
the FC, such as the Care Condom or FC2, have been
underutilized. To date, FCs only represents 0.8% of the
total condoms distributed by donor nations [3]. At-
tempts to introduce FCs worldwide have encountered
barriers such as weak distribution channels within na-
tional health systems and critiques of the product design
and marketing. The new WC product features an im-
proved design and will be coupled with a multipronged
marketing campaign that addresses some of these con-
cerns. The marketing strategy is more streamlined, with
a clearly defined target population. In piloting, the prod-
uct has received positive feedback on its design and ease
of use, and it will be marketed with a higher price point
as a premium product in urban settings.
Zambia is an important context for the introduction of
the WC. Coupled with the high unmet need for family
planning (27.1%), Zambia has an HIV prevalence of
13.3% among the general population [4], twice as high as
that in urban areas. Young women aged 18–24 years
bear a disproportionate burden of this epidemic, with an
HIV prevalence of 11.2% compared to 7.3% among men
in the same age cohort [4]. According to the 2013–2014
Demographic and Health Survey, the majority (75%) of
Zambian women reportedly have had sex by age 20, and
41% of women and 46% of men report wanting to delay
having a child by at least 2 years [4]. The total desired
fertility rate is lower in urban areas, 4.2 children versus
5.1 children in rural areas [4]. Currently, the prevalence
of any FC brand use is less than 1% [4]. Expanding ac-
cess and choices in contraceptives is important in urban
Zambia for preventing unwanted pregnancy and STI/
HIV infection, and the FC is currently not available.
In order to ensure uptake and use of a new contraceptive
method, there must be a proactive and well-planned strat-
egy to integrate it into the mix of contraceptive methods
available in a country [5]. The new WC should be viewed
within the context of a range of contraceptive choices, and
access to more options has been shown to increase overall
use of contraception. Studies suggest that different contra-
ceptive methods are used as complements, not replace-
ments [5]. It is unclear if condom users will shift their
preference from one condom brand or type to another; this
study will explore any shift in preferences after the intro-
duction of the new WC onto the market.
In addition to understanding the impact of the new WC
on the condom market, it is also critical to develop a strat-
egy to increase knowledge, acceptability, and uptake of the
new WC. During the distribution of the WC and its mass
media campaign, this randomized controlled trial (RCT)
will measure the impact of a interpersonal communication
(IPC) intervention. IPC interventions here are community
based small groups led by trained IPC agents that will dem-
onstrate proper WC use and promote conversations be-
tween sexual partners in condom negotiation to change
contraceptive norms and product acceptability. To date, no
rigorous evaluations of IPC interventions that aim to im-
prove uptake of products have been conducted, particularly
among a general population of young people. Recent re-
search does suggest that exposure to IPC is associated with
knowledge acquisition and acceptability of sensitive topics
such as condom use [6]; however, there is a lack of
causality.
This study will measure the impact of the new, pre-
mium WC on the condom market and how it impacts
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user contraceptive preferences and brand selection. This
study will also implement an RCT designed to measure
the added impact of a community-based IPC interven-
tion on improving WC (and overall condom) knowledge,
acceptability, and use, as compared with a mass media
campaign only.
Objectives and hypothesis
The overall objective of this RCT is to evaluate how the
introduction of the WC impacts the condom market in
Zambia. Specifically, we will evaluate the effectiveness of
IPC plus mass media plus distribution of WC (intervention)
compared to mass media plus distribution of WC (control)
on the prevalence of WC use and prevalence of overall con-
dom use. The conceptual framework is described in Fig. 1.
The primary objectives of this evaluation are:
1. To assess the effect of the introduction of the WC
on the overall condom market (self-reported
condom use and self-reported use of WC)
2. To determine the additional effect of an IPC
intervention on self-reported use of the WC as com-
pared with just mass media including a website
(controlling for any differences between the intervention
and control groups)
3. To determine the additional effect of an IPC
intervention on self-reported use of any condom
as compared with just mass media including a
website (controlling for any differences between
the intervention and control groups)
4. To determine the additional effect of an IPC
intervention on willingness to use an FC (and
specifically, theWC) as compared with just mass media
including a website (controlling for any differences
between the intervention and control groups)
The secondary objectives of this evaluation are:
5. To determine the effect of an IPC intervention on
self-reported knowledge, attitudes, and practices
regarding the FC, specifically the WC, as compared
with just mass media including a website (controlling
for any differences between the intervention and
control groups)
6. To determine the effect of an IPC intervention on
community-level acceptability of an FC, specifically
Fig. 1 Summary of conceptual framework
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the WC, compared with just mass media including
a website (controlling for any differences between
the intervention and control groups)
7. To determine the effect of an IPC intervention on
self-reported changes in interpersonal communication
with sexual partners regarding contraceptive use as
compared with just mass media including a website
(controlling for any differences between the intervention
and control groups)
8. To assess women’s and men’s preferences for
condom brands.
Methods/design
The overall aim of this study is to assess the impact of intro-
ducing the WC on the overall condom market. We will also
evaluate the effectiveness of IPC plus mass media plus distri-
bution of WC (intervention) compared with mass media
plus distribution of WC (control) on the self-reported preva-
lence of WC use and prevalence of overall condom use
using an RCT design. Forty urban wards in Lusaka and
nearby districts (Chilanga, Kafue, and Chongwe) will be ran-
domized to the control or intervention arm with a 1:1 allo-
cation ratio. The baseline survey conducted in all 40 wards
will be analyzed as a quasi-control arm in order to assess
the effect of the introduction of the WC on the total con-
dom market. This will be done for two reasons: (1) there are
no comparably urban areas in the country to act as control
settings; (2) the potential for spillover for a new condom
product and its marketing campaign is extremely high, mak-
ing a true control arm logistically and technically impossible.
The media campaign will be displayed on a website and
billboards throughout the city; thus these cannot be geo-
graphically limited.
When the baseline survey is implemented, no WC will
be available, as is the status quo in Lusaka. After rollout
of the WC, wards in the control arm will receive only
the WC and a mass media campaign. Intervention wards
will receive the WC, a mass media campaign, and the
IPC intervention. The RCT component of this study will
aim to evaluate the added impact of the IPC interven-
tion compared with just distribution of the WC and the
mass media campaign. The trial will be evaluated
through baseline and endline questionnaires adminis-
tered to eligible individuals residing within randomly se-
lected households located in these wards. The Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) checklist was used to prepare the study
protocol (Additional file 1). The resulting protocol
schedule of procedures and activities for this study is
outlined in Table 1 as per the SPIRIT guidelines.
Setting and participants
The new WC product is being distributed in urban
wards that comprise Lusaka, the capital of Zambia
(see map of selected wards; Fig. 2). A baseline survey
was conducted in November 2015, and an endline
survey will be conducted in March 2017, each sam-
pling from randomly selected households within 40
selected urban wards. One individual per household
will be enrolled and administered the questionnaire if
the person has lived in the house for at least the past
6 months (to ensure exposure to the WC and the
IPC intervention in the intervention wards), is be-
tween the ages of 18 and 24 years, and is sexually
active (has had sex in the last 6 months) (eligibility cri-
teria). Both men and women will be included in the study.
Intervention
The WC program comprises three components: (1) dis-
tribution of the WC, (2) a mass media campaign, and (3)
an IPC intervention. These are defined as follows:
1. Distribution of the WC: The WC will be distributed
to pharmacies and other outlets such as chemists
and stores by the SFH located in the geographic
areas where the study will be implemented. The
distribution of the WC will take place across both
study arms. Information regarding where the WC is
stocked and how often it is available will be collected
throughout the study to determine availability of the
product and whether that varies across wards.
2. Mass media campaign: The WC will be advertised
widely, targeting young adults through radio,
billboards, news media, social media, and a mobile
website. The mobile website and accompanying
media will be branded under the “Smart Choices”
campaign (SmartChoices.co.zm). The website will
serve as a main venue for the introduction and
promotion of the WC. The media campaign in its
various forms will disseminate information about
family planning and serve as an interactive forum for
young men and women to ask sexual health related
questions and generally discuss SRH related topics.
SMS blasts and social media messaging will be used
to direct individuals to the website.
3. Interpersonal communication (IPC): IPC agents will be
recruited from wards within the intervention arm. They
will be paid and trained by the SFH on communication
skills, sexual and reproductive health information,
technical specifications and use of theWC, and condom
negotiation skills with sex partners. IPC agents will set
up an IPC point in a high traffic area(s) of each ward
selected for the intervention arm for initial demand
creation, and will use their existing and new contacts to
access networks of young people in the area for smaller
group and one-on-one information sessions. The IPC
intervention will comprise communication messages
focused on how to use and the benefits of the use of
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WCs and male condoms for the prevention of un-
planned pregnancies. IPC activities will be targeted to
both young men and women (aged 18–24 years). The
IPC agents will also be young (18–35 years of age) males
and females. The key components of the IPC interven-
tion include (1) targeting men and women aged
18–24 years, (2) providing content on the importance
of contraceptive use with a focus on the benefits of
FCs, (3) demonstrating how to use theWC on a pelvic
model, and (4) training on condom use negotiations
with a sex partner through theater or role playing.
Information will also be distributed in the form of
pamphlets, and tools used for the IPC sessions will
include flip charts and tablets.
Sample size
To calculate the sample size needed in each trial arm, we
considered prevalence of any condom use (percentage) as
our outcome of interest. The contraceptive prevalence
rate (CPR) for any modern contraceptive method in urban
Zambia (for 15- to 49-year-old married women) is
currently about 53% [4]. However, our study includes both
married and unmarried women. A report from 2009 by
the Zambian Statistics Office reported urban condom use
to be 54% in Zambia [7]. We used 53% to calculate our
sample size, and aim to detect a minimum increase of 5%
use with 80% power at the 95% significance level. Because
the trial is clustered at the ward level (with many individ-
uals living within a ward), the sample size needs to be in-
creased to account for intraclass correlation (ICC) within
wards. However, no information was found from previous
studies on the likely between- or within-cluster correla-
tions in FC use in previous cluster-randomized trials.
When the ICC cannot be estimated, common practice is
to double the sample size to account for clustering.
Using Stata (StataCorp, College Station, TX, USA), we
calculated the sample size required to detect a 4%, 5%,
and 7% increase in any use from a 53% baseline use and
an estimated standard deviation (SD) of 0.15, doubling
the sample size to account for the unknown ICC. Lastly,
we added 10% to increase the sample size to account for
potential refusals. We will use a sample size of 1157
Table 1 SPIRIT protocol schedule of procedures and activities for Maximum Diva study
Study period
Prep. phase Baseline survey Randomization Intervention period Endline survey Close-out
Activity -t1 0 t1 t2 t3
Enrollment:
Sampling and mapping X
Informed consent written X
Hiring and training surveyors X
Piloting, revising survey tool X
Interventions:
Randomization X




Baseline outcomes of interest: male
condom use in last 6 months, male
condom use at last sexual intercourse,
types of contraception used, interest
in using female condom in the future
X
Endline survey X
Endline outcomes of interest: WC use
(last 6 months, last sexual intercourse),




Write up manuscripts for peer-reviewed
publication, present at relevant international
and local conferences, host dissemination
event with local stakeholders
X
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individuals per arm (a total of 2314 individuals in both
arms). This yields a total of 58 individuals to be inter-
viewed per ward, in a total of 40 wards (see Table 2).
Survey and randomization
The enrollment of participants for the baseline survey was
based upon a systematic random sampling strategy: (1) se-
lection of wards, (2) household sampling, and (3) individ-
ual sampling. These Wards were selected because they are
urban/peri-urban and comprise Lusaka, the main city of
Zambia. In order to select households, all 40 wards were
subdivided into enumeration areas (EAs) based on
household density. The centroid point of each EA was
generated using ArcGIS version 10.2 software (Esri, Red-
lands, CA, USA). Centroid points that are within 150 m of
the ward boundary were excluded, to avoid enumerators
approaching houses that are not in the selected ward. Five
EA centroid points and five back-up points will be ran-
domly selected per ward. Enumerator supervisors visited
each GPS point and directed enumerators into a Random
Walk from each selected EA centroid point, visiting every
other house in each direction. A map of Lusaka wards and
an example of the sampling strategy are detailed in Fig. 2.
Interviewers visit households in the mornings and
Fig. 2 Map of selected wards in Zambia, and sampling methodology (example: Matero ward)
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afternoons, and on weekends, when participants are likely
to be home. When the enumerator visits a selected house-
hold, he/she records a roster of individuals living in that
house. The roster assigns each individual a number, then
one individual is randomly selected for participation. If
that participant is not eligible, the next randomly selected
individual from the roster will be approached. If no one is
eligible, then the house will be labeled “no one eligible.” If
the participant is home but busy, the interviewer will
schedule an appointment for a later time. If no one is
home, the interviewer will approach one additional time.
If no one is home at the second visit, then a GPS coordin-
ate is recorded and the household labeled “no one avail-
able.” If the individual at the household refuses to
participate, then the household will be labeled “refused.”
A structured questionnaire was administered to each eli-
gible and consented individual who met the inclusion cri-
teria. Survey interviewers were either male or female and
work for Innovations for Poverty Action (IPA) Zambia.
Each interview lasted about one hour and took place in the
home but away from other household members, in private.
The questionnaire collects socio-demographic information,
information regarding condom use, sexual behavior, know-
ledge and beliefs specifically regarding condoms, contracep-
tive options, and communication with sexual partners. A
small reimbursement amount was provided to participants
who completed the survey. The study enrolled both men
and women.
After the baseline survey was completed in January
2016, all 40 wards were randomized to receive the con-
trol (WC plus mass media) or intervention (WC plus
mass media plus IPC), and were allocated by an IPA
statistician using a Stata program. Ward level population
density based on the 2010 census data, ward level pov-
erty, and average distance to the nearest health facility
were used to stratify the randomization. Additional bal-
ance checks were conducted to ensure randomization
was successful. Each ward has been mapped including
the IPC sites, and all visited houses enumerated and
given an ID. Since randomization, the IPC intervention
has been implemented in intervention wards only. Only
the IPA statistician and the implementing partner (the
SFH) know the allocation of wards. The endline survey
is planned for March 2017, and will follow the same
protocol as outlined above for the baseline survey. The
endline survey will have additional questions regarding
exposure to the mass media and IPC intervention, in-
cluding pictures to prompt recall. Households will be
randomly selected for both surveys; the same households
will not be approached.
The Consolidated Standards of Reporting Trials
(CONSORT) randomization and survey structure are
described in Fig. 3.
Primary and secondary outcomes
The primary and secondary outcomes listed below
correspond to the primary and secondary objectives.
The primary outcomes are:
1. Increase in the prevalence (percentage) of WC (self-




(c)most recent sexual intercourse.
2. Increase in the prevalence (percentage) of any
condom (self-reported) use among men and women
aged 18–24 years
(a)ever
(b)in the past 6 months
(c)at most recent sexual intercourse.
3. Increase in the willingness to use the WC in the
future among men and women aged 18–24 years.
The secondary outcomes are:
4. Self-reported increase in knowledge, improved
attitudes, and practices of both male and female
condoms after attending IPC intervention
5. Self-reported increase in acceptability (community
awareness) of FCs
6. Self-reported improvement in communication with
sexual partner(s) regarding use of male and/or
female condoms for STI prevention and/or family
planning
7. Self-reported condom brand preference before and
after rollout of the WC.
Table 2 Sample size required to detect a 2, 3, and 4 percentage point increase in condom use (4%, 5%, and 7% increase)
Hypothesized standard
deviation of condom use
Hypothesized increase in proportion
of condom use between groups
Sample size required in
each group (ratio 1:1)
Adjusted for effect of
clustering (design effect = 2)
10% refusal rate
(estimated)
0.15 7% 296 592 651
0.15 5% 526 1052 1157
0.15 4% 1183 2366 2603
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Process evaluation
The RCT will be complemented by a process evaluation
that is being conducted between the baseline and endline
data collections. After the baseline survey was conducted,
the intervention was rolled out: the WC is now be avail-
able throughout Lusaka coupled with the mass media
campaign. The IPC intervention is being implemented in
the randomly selected intervention wards. Since comple-
tion of baseline, IPA and SFH have been carrying out a
process evaluation to assess the fidelity of the various
components of the WC project as well as penetration of
the IPC intervention. This is being done to assess the fol-
lowing: (1) availability and distribution of the WC, (2)
tracking of the mass media campaign, (3) penetration and
reach of the IPC intervention, and (4) acceptability of the
WC.
First, to monitor the availability and distribution of the
WC, we will review monitoring data from SFH to track
the availability of the WC throughout Lusaka. SFH is
keeping track of distributions of the WC to determine
how many WC products are purchased throughout the
year. To assess availability to potential customers, we are
implementing mystery shopper techniques to visit phar-
macies and other distribution venues in all wards to de-
termine if the WC is available and in stock. This can be
cross-compared with records kept by the SFH of how
many WCs have been purchased and distributed
throughout Lusaka.
Second, we are working with SFH to ensure that all
components of the mass media intervention are consist-
ently rolled out, for example, checking that the website
is up to date and the pages are successfully loading. The
billboards are being checked periodically to ensure that
they are still being viewed.
Third, we are working with SFH to randomly visit
IPC recruitment and sessions. We are conducting
“spot checks” and attending a random selection of
IPC activities to determine if the IPC is being imple-
mented and if the IPC agent is adhering to the train-
ing curriculum and key components of the
intervention. We are also comparing logs with IPC
agents regarding how many individuals attend the
IPC. IPC agents are collecting ”client forms” during
IPC sessions to provide information on the number
of participants, date, location, and gender composition
of the sessions. We have developed and implemented
monitoring tools to collect information at the IPC
sessions on participation, quality of delivery, and fre-
quency of IPC sessions in each ward to measure the
intervention intensity and penetration. The evaluation
team is also monitoring the process of setting up IPC
appointments and tracking (on random visits) how
many invitations for IPC are sent out to measure
take-up of the intervention. This is running parallel
to the administrative/monitoring data that SFH is
collecting.
Fig. 3 CONSORT flow diagram of study design
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Lastly, 30 qualitative focus group discussions are
being conducted to understand how the WC product
is being received in the communities. SFH may also
collect short user surveys or collect qualitative data
that can be shared. This will help determine if the
product is available and if the mass media is being
seen/accessed. It will also help us understand any
reactions to the WC, how the messaging is being
interpreted, and the acceptability of the new product
to the community.
The evaluation team will work closely with the SFH
team to ensure all administrative data needed for analysis
are collected during the intervention. We will also note if
any other major SRH activities are occurring throughout
the study period, for example, any other products added
to the market, any major stockouts of existing products,
or any widespread education campaigns that might impact
the IPC intervention. Overall this process evaluation will
determine key factors that may impact the outcomes of
the IPC intervention (i.e., availability of the WC, the
consistency of the media campaign, and the quality of and
reach of the IPC intervention). The process evaluation
began when the project was rolled out, and is ongoing
until the endline survey begins.
Data management and analysis plan
The data are collected into an Android phone using Sur-
veyCTO software; the data obtained are cleaned and
exported into Stata for analysis. A high frequency check is
run every two to three days to highlight any errors in data
collection. Twenty percent of all participants (eligible or
ineligible) are being randomly selected for back checking.
The back check includes confirmation of ineligibility or
administration of a 5- to 10-min version of the original
survey to compare responses. All data are encrypted using
Boxcryptor and stored on the SurveyCTO cloud and Box.
A de-identified version of the data and statistical code will
be shared on Dataverse at the completion of the study.
We will report the trial according to the CONSORT
standards for reporting RCTs. This is a behavioral inter-
vention unlikely to produce adverse effects, so analysis will
be undertaken immediately once the endline survey has
been completed. Baseline survey data will be analyzed to
measure differences between the groups and between the
wards at baseline. Randomization can be checked at this
point. The main analysis will take place after endline data
have been collected, to measure the impact of the intro-
duction of the WC and the IPC intervention on condom
use, controlling for any potential confounders or explana-
tory factors detected from the baseline analysis.
To assess the impact of the introduction of the new
and premium WC on the Zambian condom market,
the evaluation team will use the baseline survey as a
quasi-control arm. While there are limitations with
this approach, it will allow for measurement of
changes in condom use, brand switching, user prefer-
ences, and uptake of the new product. The main limi-
tation is that the study cannot determine attribution;
however, given the challenges to create a better coun-
terfactual, the evaluating and implementing teams
agreed that this is the best approach in view of pro-
grammatic constraints.
The baseline survey will occurred at a time when there
was no WC product available, no mass media, and no IPC.
The study outcomes are self-reported condom (male or fe-
male) use ever, during the past 6 months, and at last sexual
intercourse. The study will measure these indicators at
baseline (no WC available) and endline (WC available). By
analyzing changes in these indicators, the study will show
changes in overall condom use as well as uptake of the WC
in areas with only mass media versus mass media and IPC.
For the RCT component of the study, we will analyze the
impact of the IPC intervention on our outcomes of interest
(male condom use, WC use, willingness to use the WC),
comparing intervention to control wards. Analyses will be
conducted in Stata v12 (StataCorp, College Station, TX,
USA). Results will be adjusted for any ward level clustering
if it is identified. Multivariate regression analyses will be
carried out to determine the impact of the IPC intervention
on condom use (male condom and WC), controlling for
demographic characteristics of participants.
Statistical methods
For the primary and secondary outcomes we will esti-
mate odds ratios with 95% confidence intervals. We
will calculate the rates of self-reported contraception
use per ward and willingness to use the WC. Descrip-
tive analyses will be conducted, and several regression
models will be run to determine the impact of IPC
on each outcome variable of interest. All regression
models will control for baseline characteristics of rele-
vance to the outcome (either as potential confounders
or as explanatory factors). Backward elimination
methods will be used to remove non-statistically sig-
nificant factors that do not improve the fit of the
model and do not confound other associations ob-
served. Multilevel models may be implemented to
control for individual and ward level correlation, as
individuals are nested within wards.
Ethics
Individuals who meet the study inclusion criteria will
give written informed consent. The interviewer will
inform the participant that a study is being conducted
on contraception, specifically knowledge and use of FCs,
in order to improve SRH outcomes for this community,
and that their time is very much appreciated and valued.
The participant will receive an information sheet with
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additional details regarding the study in which they are
enrolling. After this step, the participant will receive and
sign for the small compensation (30 kwacha of talk
time), and the questionnaire can be administered. Inter-
viewers will conduct the survey in a private area to pro-
tect anonymity and reduce the likelihood that responses
are influenced by external household factors.
The questionnaires will be assigned an anonymous ID
number, and de-identified. They will be stored safely and
not accessed by anyone except the evaluation team
(principal investigators, co-investigators, and analysts),
for confidentiality. All personal identifying information
(PII) will be removed from the dataset. This study has
received approval from both IPA’s and Zambia’s institu-
tional review boards, IRB (IRB No. 10854) and Excel-
lence in Research Ethics and Science (ERES) Converge
(IRB No. 00005948). Any modifications to the protocol
or survey will be submitted to both IRBs for review but
are not anticipated. We have also received Zambia’s
Ministry of Health’s approval to implement the study.
The informed consent form and information sheet are
provided in Additional file 2.
Discussion
Results from the trial will provide rigorous evidence on
the impact of introducing the new WC product on overall
condom use and effective strategies to increase know-
ledge, acceptability, and uptake. This trial will contribute
towards the evidence base on social marketing of con-
doms and community-based IPC interventions to increase
uptake. The focus on young adults in urban areas and
their knowledge and use of contraceptives has not been
well studied. This trial is aimed at understanding the
introduction of a novel contraceptive product to urban
youths, and is unique in a number of ways.
First, this is the only RCT of the newly designed and
marketed WC in urban sub-Saharan Africa. No studies
have evaluated the impact of introducing a premium FC
product (the WC) in a market where male condoms and
the FC2 have been available. Further, an impact evaluation
of social marketing comprised of mass media and an IPC
intervention to increase condom use among a general
population of young adults has never been conducted, al-
though smaller studies between 1990 and 2010 suggest
that social marketing can increase condom use [8]. One
recent cluster RCT measured the impact of a Facebook
page on the use of condoms for STI prevention and found
a positive effect, but noted that it diminished over time [8].
Studies suggest that, despite their widespread availability
and low cost, male condoms are not used as often or as
consistently as they should be; therefore, adding the WC
to the market could increase the levels of protected sex
overall [9]. Studies suggest that when both types of con-
doms are available, consistent users will alternate male and
female condoms as complements, not replacements for
each other [9]. The WC may also be used more by long-
term couples, whereas male condom use decreases signifi-
cantly once relationships are defined [10]. The WC may
serve as an alternative for women who are not able to ne-
gotiate male condom use [10].
Second, this is the first RCT of a community-based IPC
intervention led by paid, trained IPC agents and targeting
the general youth population. Some recent studies have
highlighted aspects of IPC that can make it more success-
ful, such as inclusion of stories and dialogue, demonstra-
tions, role playing, games, and negotiation skills. IPC
interventions that are dialogue-based are well suited for
promoting openness and discussion about sensitive or
stigmatizing topics such as condom use among couples
and peer networks. Social networks can be used to diffuse
information about condoms and reinforce condom use
norms through IPC, increasing acceptability [11]. Previous
programs or interventions with messages highlighting the
positive benefits of the FC (e.g., increased sexual pleasure
and autonomy) may also increase uptake [3]. IPC inter-
ventions that include demonstrations can be critical in im-
proving women’s comfort level with FCs and shift
attitudes towards the FC [12]. Women report that the
overall acceptability of the FC improves over time with
practice [13–15]. A US trial found the strongest predictors
of FC use were having had instruction and skills training,
and intending to use the method [16]. Knowing how to
use an FC and feeling comfortable with insertion is
critical, and initial findings suggest that demonstration is a
necessary component for a successful rollout.
No single trial or initiative will answer the question of
how the WC specifically will impact the condom market,
and whether uptake will increase with mass marketing
and IPC intervention. This trial will provide evidence on
effectiveness of IPC interventions for increasing know-
ledge, acceptability, and uptake of the WC and condoms,
generally. The generalizability of these findings may de-
pend on the marketing of the WC and the culture in
other regions of Zambia or in a different region. For ex-
ample, the promotion of the FC as a woman-controlled
method backfired in some countries because male part-
ners viewed FCs as threatening to their control over
their partner’s sexual behavior [17, 18].
Recommendations on the impact of IPC approaches for
increasing condom uptake and other SRH services will be
developed based on the results of this trial. Findings will
be written into a report for PSI and WomanCare Global,
and a paper will be submitted for publication to a peer-
reviewed journal. The evaluation team will work closely
with the SFH and PSI to organize a dissemination event
subsequent to the completion of the study to share results
with local and global stakeholders (government officials,
non-governmental organizations (NGOs), international
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NGOs (INGOs), donors) working on SRH research, pro-
grams, and policies in Zambia and at the global level.
Trial status
At the time of submission, the trial is completing the inter-
vention period and planning an endline cross-sectional
survey for January 2017.
Additional files
Additional file 1: SPIRIT 2013 Checklist: Items addressed for the
Maximum Diva Woman’s Condom Randomized Controlled Trial. (DOC
123 kb)
Additional file 2: Informed consent form and participant information
sheet (English) for the Maximum Diva Woman’s Condom Randomized
Controlled Trial. (DOCX 18 kb)
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